| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 21, 2026 | ±1.9% | -0.5% | over-priced |
| October 21, 2025 | ±2.3% | +5.9% | under-priced |
| July 22, 2025 | ±2.5% | +1.0% | over-priced |
| April 22, 2025 | ±3.0% | +3.8% | under-priced |
| October 22, 2024 | ±2.2% | -4.0% | under-priced |
| July 23, 2024 | ±2.8% | +5.3% | under-priced |
| April 23, 2024 | ±1.9% | +7.2% | under-priced |
| October 24, 2023 | ±2.5% | -3.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.45 | $6.0B | $1.0B |
| Q4 FY2025 | $1.68 | $6.8B | $1.2B |
| Q3 FY2025 | $1.27 | $6.1B | $908M |
| Q2 FY2025 | $0.77 | $5.9B | $555M |
Danaher Corporation (DHR) reports in 83 days, with the next report estimated for September 4, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 3.9% on average — the market has tended to under-price DHR's earnings risk. Fundamentals into the print: EPS up 9.8% year-over-year, revenue up 3.7%. QuantLogix's live 5-factor engine currently reads DHR as a neutral at 43/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →